Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

ARDIGEN S A

🇵🇱Poland

Country: 🇵🇱Poland

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

4

Active:0

Completed:1

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Creating an Innovative AI-based Technology TCRact for Designing and Optimizing T-cell Receptors (TCR) for Use in Cancer Immunotherapies

Completed

Conditions: Colon Cancer
Cancer

First Posted Date: 2021-08-06

Last Posted Date: 2024-06-26

Lead Sponsor: Ardigen

Target Recruit Count: 118

Registration Number: NCT04994093

Locations: 🇵🇱
Maria Sklodowska-Curie National Research Institute of Oncology, Kraków, Poland

Polish Microbiome Map

Conditions: Melanoma
Healthy Volunteers
Immunotherapy
Microbiome
Metagenome

First Posted Date: 2019-11-20

Last Posted Date: 2019-11-20

Lead Sponsor: Ardigen

Target Recruit Count: 1160

Registration Number: NCT04169867

Locations: 🇵🇱
The Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznań, Poland

AImmune - Artificial Intelligence Algorithm for Identification of Immunogenic Neoepitopes of Cancer to Predict and Boost Patient's Response to Immunotherapies.

Conditions: Non Small Cell Lung Cancer
Neoantigens
Neoepitopes
Immunotherapy
Next Generation Sequencing (NGS)
Personalized Neoantigen Cancer Vaccine

First Posted Date: 2019-10-30

Last Posted Date: 2020-08-10

Lead Sponsor: Ardigen

Target Recruit Count: 30

Registration Number: NCT04145232

Locations: 🇵🇱
University Clinical Centre in Gdansk, Gdańsk, Poland

BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics

Conditions: Metagenome
Melanoma
Non Small Cell Lung Cancer
Immunotherapy
Microbiome

First Posted Date: 2019-10-23

Last Posted Date: 2020-08-10

Lead Sponsor: Ardigen

Target Recruit Count: 130

Registration Number: NCT04136470

Locations: 🇵🇱
University Clinical Centre in Gdansk, Gdańsk, Poland
🇵🇱
The John Paul II Hospital in Krakow, Kraków, Poland
🇵🇱
The Maria Sklodowska-Curie National Research Institute of Oncology Krakow Branch, Kraków, Poland

and more 7 locations

News

No news found

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy